This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

David V. Becker, MD; S. Thomas Bigos, MD; Eduardo Gaitan, MD; John C. Morris III, MD; Marvin L. Rallison, MD; Carol Ann Spencer, PhD, MT; Masahiro Sugawara, MD; Lester Van Middlesworth, PhD, MD; Leonard Wartofsky, MD
American Thyroid Association Washington, DC

JAMA. 1993;269(21):2736-2737.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—The American Thyroid Association (ATA) in 1990 and 1991 issued guidelines for use of laboratory tests in thyroid disorders.^1,2 These ATA position papers update previous recommendations because of the development and availability of improved thyrotropin (thyroid-stimulating hormone [TSH]) methods capable of clearly separating normal from subnormal serum TSH levels. The highly sensitive TSH assay constitutes a practical, useful, and significant laboratory advance in clinical thyroidology. There is agreement among thyroid specialists that measurement of serum TSH level, complemented by an appropriate free thyroxine (FT₄) estimate, represents the best and most efficient combination of blood tests for diagnosis and follow-up of most patients with thyroid disorders.

Currently in the investigation of thyroid disease there is a trend to replace a combination of tests (eg, total T₄ + triiodothyronine resin uptake + FT₄ + total T₃ + TSH) by a discriminating single thyroid function test. This trend reflects . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?